Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

For dividend-seeking investors, a buoyant stock market can be a little annoying. Stock prices rising faster than profits ...

This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.